Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines

Molecular Genetics and Metabolism

Volumn 90, Issue 1, 2007, Pages 37-41

  Kern, R M ^a   Yang, Z ^a   Kim, P S ^a   Grody, W W ^a   Iyer, R K ^a   Cederbaum, S D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arginase; Induction; Phenylbutyrate; Urea cycle

Indexed keywords

ARGINASE; ARYLBUTYRIC ACID DERIVATIVE; SODIUM PHENYLBUTYRATE;

ANIMAL TISSUE; ARTICLE; BRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LOCALIZATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARGINASE; CELL LINE; ENZYME INDUCTION; HUMANS; ISOENZYMES; LIVER; MALE; MICE; MICE, INBRED C57BL; PHENYLBUTYRATES;

RODENTIA;

EID: 33845220139     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2006.07.002     Document Type: Article

References (18)

1. Brusilow S.W., and Horwich A.L. Urea cycle enzymes. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eighth ed. (2001), McGraw-Hill, New York 1909-1963
2. Crombez E.A., and Cederbaum S.D. Hyperargininemia due to liver arginase deficiency. Mol. Genet. Metab. 84 (2005) 243-251
3. Cederbaum S.D., Shaw K.N.F., Spector E.B., Verity M.A., Snodgrass P.J., and Sugarman G.I. Hyperargininemia due to arginase deficiency. Pediatr. Res. 13 (1979) 827-833
4. Spector E.B., Rice S.C.H., and Cederbaum S.D. Immunologic studies of arginase in normal human adults and fetal tissues and in patients with arginase deficiency. Pediatr. Res. 17 (1983) 941-944
5. Vockley J.G., Jenkinson C.P., Shuklal H., Kern R.M., Grody W.W., and Cederbaum S.D. Cloning and characterization of the human type II arginase gene. Genomics 38 (1996) 118-123
6. Gotoh T., Sonoki T., Nagasaki A., Terada K., Takaguchi M., and Mori M. Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine-like cell line. FEBS Lett. 395 (1996) 119-122
7. Morris Jr. S.M., Bhamidipati D., and Kepka-Lenhart D. Human type II arginase: sequence analysis and tissue-specific expression. Gene 193 (1997) 157-161
8. Grody W.W., Kern R.M., Klein D., Dodson A.E., Wissman P.B., Barsky S.H., and Cederbaum S.D. Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme. Hum. Genet. 91 (1993) 1-5
9. McGuinness S., Zhang H.-P., and Smith K.D. Evaluation of pharmacological induction of fatty acid β-oxidation in X-linked adrenoleukodystrophy. Mol. Genet. Metab. 74 (2001) 256-263
10. Spector E.B., Kern R.M., Haggerty D.F., and Cederbaum S.D. Differential expression of multiple forms of arginase in cultured cells. Mol. Cell. Biochem. 66 (1985) 45-53
11. Jenkinson C.P., and Grigor R.G. Rat mammary arginase: isolation and characterization. Biochem Med. Metab. Biol. 51 (1994) 156-165
12. Brusilow W., Tinker J., and Batshaw M.L. Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis. Science 207 (1980) 659-661
13. Collins A., Pearson H., Giardina P., McDonagh K., Brusilow S., and Dover G. Oral sodium phenylbutyrate therapy in homozygous beta-thalassemia: a clinical trial. Blood 85 (1995) 43-49
14. Wei H.-W., Kemp S., McGuinness M.C., Moser A.B., and Smith K.D. Pharmacologic induction of peroxisomes in peroxisome biogenesis disorders. Ann. Neurol. 47 (2000) 286-296
15. Kerem E. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy. Pediatr. Pulmonol. 40 (2005) 183-196
16. Resar L.M., Segal J.B., Fitzpatrick L.K., Friedmann A., Brusilow S.W., and Dover G.J. Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy. J. Pediatr. Hematol. Oncol. 24 (2002) 700-703
17. Uchino T., Snyderman S.E., Lambert M., Qureshi I.A., Shapira S.K., Sansaricq C., Smit L.M., Jacobs C., and Matsuda I. Molecular basis of phenotypic variation in patients with argininemia. Hum. Genet. 96 (1995) 255-260
18. Scaglia F., Carter S., O'Brien W.E., and Lee B. Effect of alternative pathway therapy on branch chain amino acid metabolism in urea cycle disorder patients. Mol. Genet. Metab. 81 (2004) S79-S85